http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014161897-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68419821509aa996526fb99439b0bb04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-616 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-616 |
| filingDate | 2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f10ddc042da6f4ceaab027c1d165a9e8 |
| publicationDate | 2014-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2014161897-A1 |
| titleOfInvention | Method for treating cancers, such as myeloma and breast cancer, with a combination of tbl-12 and velcade |
| abstract | The invention relates to the use of TBL-12 in combination with at least one drug known to be effective against a specific cancer, but at a dose below its minimal effective dose when used alone. Among the types of cancer contemplated for treatment are multiple myeloma, breast, prostate, and cervical cancer. For multiple myeloma, combination with Velcade is envisioned. |
| priorityDate | 2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.